Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine

Showing 15 posts of 293 posts found.

GSK image

GSK shingles vaccine on form

December 19, 2014
Sales and Marketing GSK, HZ/su, Merck, Vaccine, Zostavax, shingles

GlaxoSmithKline will be celebrating following the successful Phase III study of its shingles vaccine HZ/su that has met its primary …

News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

News
Vaccine image

Gavi pledges $300 million for Ebola vaccines

December 12, 2014
Manufacturing and Production, Sales and Marketing GAVI, GSK, GlaxoSmithKline, J&J, JJ, Merck, Vaccine, WHO, newlink

The global vaccines alliance Gavi has committed to buying Ebola vaccines as soon as the World Health Organization recommends one …

News
Novartis image

Novartis flu vaccine cleared following safety probe

December 3, 2014
Sales and Marketing GSK, Novartis, Vaccine, flu, fluad

The Italian drugs safety agency has cleared the Novartis influenza vaccine Fluad, after an investigation found the vaccine was not …

News
GSK image

GSK Ebola vaccine ‘promising’ in early trials

November 27, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines

The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …

News
J&J image

J&J announces ‘major commitment’ to Ebola effort

October 22, 2014
Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …

News
BMS image

BMS therapeutic cancer vaccine given swift FDA appraisal

September 29, 2014
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, Vaccine, bristol myers-squibb, keytruda, melanoma, opdivo

Bristol-Myers Squibb has been granted a speedy review for its new cancer immunotherapy drug Opdivo by the FDA for patients …

News

Campaigners urge for HPV vaccine to be extended to boys

September 22, 2014
Manufacturing and Production, Sales and Marketing HPV, Vaccine, boys, girls, human papilloma virus, rsph

Public health experts are meeting today to discuss whether boys as well as girls should be offered the HPV jab. …

News
GSK image

GSK Ebola vaccine underway

August 11, 2014
Research and Development, Sales and Marketing Africa, Ebola, GSK, Vaccine, WHO, johnson

Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …

News
GSK image

GSK manufacturing woes continue

July 8, 2014
Manufacturing and Production Canada, FDA, GSK, Paxil, Vaccine, manufacturing

Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …

News
John Johnson image

Dendreon chief resigns from struggling firm

June 10, 2014
Medical Communications, Sales and Marketing Cancer, Dendreon, John Johnson, Provenge, Vaccine, Watson, prostate

Chief executive of Dendreon John Johnson is to step down in the summer amid falling sales of the company’s key …

News
Vaccine image

Child flu pilot ‘encouraging’

June 9, 2014
Research and Development, Sales and Marketing UK, Vaccine, chid, children, flu, government, phd

Figures from the child flu vaccine pilot launched last year by Public Health England (PHE) are encouraging, the government says. …

News

GAVI vaccine group call for $7.5 billion funding

May 20, 2014
Medical Communications, Sales and Marketing GAVI Alliance, Vaccine, WHO, rotavirus vaccine

The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …

News
GSK image

Lung cancer vaccine dropped

April 2, 2014
Research and Development, Sales and Marketing GSK, MAGE-A3, NSCLC, Vaccine, lung cancer, magrit

GlaxoSmithKline took a hit today after its lung cancer vaccine MAGE-A3 failed to benefit patients. The London-based firm has now …

News

Novartis pays out for US biotech

February 17, 2014
Research and Development, Sales and Marketing Cancer, Novartis, Vaccine, costim pharmaceuticals

Novartis is looking to shore up its cancer immunotherapy pipeline with the purchase of oncology specialist CoStim Pharmaceuticals. The Cambridge, …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025

Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer

December 3, 2025

Medicus Pharma shares updates on basal cell carcinoma trials

December 2, 2025

Arnold & Porter appoints George Jenkins as partner

December 2, 2025

Safeguarding health and well-being for employees – the value of occupational health services

December 1, 2025